ABSTRACT Background: Reproduction has been identified as an important factor for long-term weight gain among women. A previous efficacy trial has successfully produced postpartum weight loss; however, the effectiveness of this intervention needs to be established. Objective: This study was designed to evaluate the short-and longterm effectiveness of a diet behavior modification treatment to produce weight loss in postpartum women within the primary health care setting in Sweden. Design: During 2011-2014, 110 women with a self-reported body mass index (BMI; in kg/m 2 ) of $27 at 6-15 wk postpartum were randomly assigned to the diet behavior modification group (D group) or the control group (C group). Women randomly assigned to the D group (n = 54) received a structured 12-wk diet behavior modification treatment by a dietitian and were instructed to gradually implement a diet plan based on the Nordic Nutrition Recommendations and to self-weigh $3 times/wk. Women randomly assigned to the C group (n = 56) were given a brochure on healthy eating. The primary outcome was change in body weight after 12 wk and 1 y. The retention rate was 91% and 85% at 12 wk and 1 y, respectively. Results: At baseline, women had a median (1st, 3rd quartile) BMI of 31.0 (28.8, 33.6), and 84% were breastfeeding. After 12 wk, median weight change in the D group was 26.1 kg (28.4, 23.2 kg) compared with 21.6 kg (23.5, 20.4 kg) in the C group (P , 0.001). The difference was maintained at the 1-y follow-up for the D group, 210.0 kg (211.7, 25.9 kg) compared with 24.3 kg (210.2, 21.0 kg) in the C group (P = 0.004). In addition, the D group reduced BMI, waist circumference, hip circumference, and body fat percentage more than did the C group at both 12 wk and 1 y (all P , 0.05). Conclusion: A low-intensity diet treatment delivered by a dietitian within the primary health care setting can produce clinically relevant and sustainable weight loss in postpartum women with overweight and obesity. This trial was registered at clinicaltrials.gov as NCT01949558.
INTRODUCTION
Considering the numerous comorbidities associated with obesity, the near doubling of the worldwide obesity prevalence between 1980 and 2008 is a serious public health problem with major implications for life expectancy, quality of life, and health care costs (1) (2) (3) . In women, pregnancy has been identified as an important factor for long-term weight gain (4) (5) (6) . This is mainly explained by excessive gestational weight gain followed by postpartum weight retention, a weight trajectory exacerbated by pre-existing overweight or obesity and cumulative with each reproductive cycle (4) (5) (6) (7) (8) . Studies have shown that excess fat mass gained and retained through a reproductive cycle tends to be centrally rather than peripherally distributed (9, 10) which is correlated with an increased risk of developing cardiovascular disease (11, 12) . Further, a recent report among 450,000 women from the Swedish Medical Birth Register revealed an incremental increase in risk of stillbirth with increasing weight gain between the first and second pregnancies, with an RR of 1.55 for women who gain $4 BMI units between pregnancies compared with those who maintain a stable BMI. The authors also found a weight gain-related increase in infant mortality in offspring of women with a BMI within the normal weight category in their first pregnancy (13) . Interpregnancy weight gain has also been reported to increase the risk of maternal complications such as pre-eclampsia, gestational diabetes, and cesarean delivery in the subsequent pregnancy; however, preconceptional weight loss may reduce the risk of adverse outcomes (14, 15) . Hence, identifying effective interventions that can help women break the vicious cycle of continuous weight gain with each reproductive cycle may reduce the risk of complications during pregnancy and potentially improve long-term health.
During the postpartum period, the convergence of several contextual facilitators such as increased energy requirement during lactation (16) , motivation to return to prepregnancy weight (17) (18) (19) and desire to serve as a parental role model (20, 21) , contribute to making this time period a unique opportunity to promote healthy lifestyle changes among women. Based on this conceptual framework, our research group has previously conducted an efficacy trial, the LEVA 7 (Lifestyle for Effective Weight loss during Lactation) Study (22) , to identify which treatment program may help postpartum women to obtain sustainable lifestyle changes to lose weight after pregnancy. In that study, a 12-wk structured diet behavior modification treatment produced clinically relevant weight loss of 9% that was sustained at 10% at the 1-y follow-up. However, results from controlled efficacy trials do not constitute sufficient basis to launch new treatment programs within health care because studies of implementation in real life are necessary to translate research findings into clinical practice (23) . Thus, the LEVA in Real Life study (NCT01949558) was designed to examine the short-and long-term effectiveness of a diet treatment to produce weight loss among postpartum women when conducted within the primary health care setting. Here, we present the primary outcomes, i.e., changes in body weight and associated anthropometric and treatment-related changes in dietary intake and physical activity at the 12-wk and 1-y follow-ups.
METHODS

Study participants
During 2011-2014, 110 women with a self-reported BMI (in kg/m 2 ) of $27 at 6-15 wk postpartum were recruited through midwives and flyers at antenatal and child care clinics, as well as via advertisements in shopping centers, web journals, social media sites, and newspapers in Gothenburg and 7 surrounding municipalities in Sweden. The lower BMI criterion was limited to 27 to allow women to reach the intervention weight-loss goal without overtreating normal-weight women. The exclusion criteria included serious disease in woman or child, participation in another weight trial, and inability to assimilate written study material in Swedish. The study was approved by the regional ethical committee in Gothenburg and was conducted in accordance with the Helsinki Declaration of 1975 as revised in 1983. Written informed consent was provided by all women at study entry.
Study design
The study was a 2-arm randomized controlled trial with women attending primary health care clinics for baseline measurements and group allocation at 6-15 wk postpartum. The baseline assessment included anthropometric measures and a questionnaire on demographic, medical, and lactation characteristics. Women were randomly assigned to the diet behavior modification group (D group) or the control group (C group) through a simple randomization procedure that used numbered and sealed envelopes generated through a random number table prepared by the project coordinator. Study measurements were conducted at baseline, intervention termination (indicated as 12 wk) and 9 mo later (indicated as 1 y). All study measures and administration of intervention were completed by 2 dietitians at the primary health care clinics. Blinding of the study dietitians was not possible for practical reasons.
Study groups
Women randomly assigned to the D group (n = 54) were instructed to complete a diet record for 4 consecutive days after the baseline visit. They were asked not to divert from their usual food choices or habits because their diet record would be used to construct the diet plan. Within 1-2 wk of the baseline visit, women in the D group met for a face-to-face visit with the dietitian for 1.5 h of structured individual diet behavior modification treatment at the primary health care clinics. The diet treatment was adapted from the LEVA trial (18, 22, 24, 25) and aimed to achieve an energy intake reduction of 500 kcal/d with a nutrient composition according to the Nordic Nutrition Recommendations 2004 (26) . These recommendations emphasize a dietary composition of total fat ,30% of energy intake, saturated fat #10% of energy intake, protein 10-20% of energy intake, carbohydrate 50-60% of energy intake, and fiber $12.5 g/1000 kcal. The diet plan was communicated in terms of foods and food groups and consisted of 4 key dietary principles to be implemented one at a time, according to a step-wise body weight-determined plan to achieve the weekly weight loss goal of 0.5 kg and a final loss of 6 kg after 12 wk. The 4 key dietary principles were: 1) limit consumption of sweets, salty snacks, and caloric drinks to 1 d/wk and a maximum of 100 g/wk; 2) substitute regular foods with low-fat and/or low-sugar alternatives marked with the "green keyhole," a voluntary labeling symbol for food producers provided by the Swedish National Food Administration indicating foods that contain less sugar, fat, and salt and more whole grains and fiber [all prepackaged foods that fulfill the criteria are eligible to carry the symbol, whereas fish and seafood, fruits, vegetables, and potatoes can be labeled without packaging (27)]; 3) cover one-half of the plate with vegetables at lunch and dinner by applying the "plate model," an illustration of the proportions between the meal components (28); and 4) reduce portion sizes. Women were provided with suggestions on concrete changes in food choices to the reported baseline diet in accordance with these 4 key dietary principles and calculations on the potential weekly and total weight loss that could be achieved if the principles were implemented (24) . The diet plan was presented in a printed booklet covering the dietary principles, the weekly and final weight-loss goals during the intervention, the instructions to self-weigh $3 times/wk, and guidance on how to use body weight as a proxy for energy balance to adjust energy intake during the intervention. Strategies to manage barriers to change identified by each woman were established jointly between the woman and the dietitian and noted in the booklet (e.g., avoid keeping sweets and salty snacks at home to limit access to easily accessible energy-dense snacks). Finally, the booklet covered some general advice to increase physical activity, and women were encouraged to set a specific exercise goal such as taking brisk walks with the stroller 4 times/wk. During the intervention period, women were contacted biweekly by the dietitian with standardized cell phone text messages and asked to report current body weight and provided with personalized reinforcement and feedback on their progress. The text message after 6 wk of intervention was replaced with a telephone call to allow for questions and more thorough feedback. Women randomly assigned to the C group (n = 56) received no diet treatment, text messages, or telephone call but were instead given a brochure on healthy eating at the baseline visit. The brochure included advice on regular meal patterns, the plate model, selecting low-fat alternatives labeled with the green keyhole, reducing energy-containing beverages and a recommendation to aim for a weight-loss rate of 0.5 kg/wk. Both groups received routine postnatal care at the maternal health care clinics and were offered the treatment and material of the alternative study group after final follow-up.
After intervention
During the 9 mo after intervention termination, standardized monthly e-mails were sent to women in the D group to increase the likelihood of establishing sustainable lifestyle changes. The e-mails included information on topics such as the 4 key dietary principles, physical activity, how to deal with the return to work after maternity leave, and strategies for weight-loss maintenance. Women were also asked to report their current body weight and provided with individualized reinforcement and feedback by the dietitian through e-mail correspondence.
Study measurements
Dietary intake
An unannounced, telephoned 24-h recall was performed with all women a few days before all 3 study visits to assess dietary intake. Details on the rationale and methodology of the 24-h recall have been described previously (29) . In short, women were asked to recall all foods and beverages consumed from midnight to midnight during the preceding whole 24-h period and to quantify the amounts by use of weights and volumes, household measures, or a booklet of 2-dimensional photographs of different portion sizes of foods (30) that had been issued to the women before each of the 3 study visits. The interviews covered dietary intake during Monday through Thursday and were conducted by the study dietitians. Dietary intake was calculated by use of the software Dietist XP (version 3.2; Kost och Näringsdata) based on the Swedish Food Database 2010 and data from food manufacturers. All dietary data presented exclude supplement intake.
Step count
Step counts were measured for 7 consecutive days before the study visits by use of a validated pedometer (Omron Walking Style Pro HJ-720IT-E2) (31) that had been sent to the women before each of the 3 study visits. Women were instructed to wear the pedometer at the hip, in a pocket, or hanging from the neck by a key chain cord from the time they woke-up until bedtime and not to divert from their usual physical activity. The step counts were analyzed by use of the Omron Health Management Software (version E1.012; Omron Healthcare).
Anthropometry
Height was measured without shoes via a wall-mounted stadiometer to the nearest 0.1 cm at the baseline visit. Weight was measured to the nearest 0.1 kg, and body fat was estimated with bioelectrical impedance by use of an electronic scale [Omron BF508 (32) ], with the women in light clothing and bare feet with arms held vertically while gripping the hand electrodes. Waist circumference was measured at the approximate midpoint between the lower margin of the last palpable rib and the top of the iliac crest, and hip circumference around the widest portion of the buttocks by use of a measuring tape. Waist-to-hip ratio was determined by dividing the waist circumference with the hip circumference. BMI was calculated from weight in kilograms divided by the square of height in meters. Prepregnancy BMI was calculated as self-reported prepregnancy weight divided by the square of measured height, and gestational weight gain was obtained by self-report at the baseline visit.
Statistical analysis
The primary outcome was change in weight after 12 wk and 1 y. Power calculations showed that a sample size of 106 women would have 90% statistical power (a = 0.05, 2-sided test) to detect a difference in weight loss of 3.0 kg at 1 y [25.0 6 4.0 kg in the D group and 22.0 6 4.0 kg in the C group based on results from the LEVA trial (22) and accounting for a more heterogeneous sample], allowing for 30% attrition. Other anthropometric and treatment-related secondary outcomes were changes in BMI, waist circumference, hip circumference, percent body fat, dietary intake, and physical activity.
Linear mixed models were used to identify statistically significant differences in outcome measures between the 2 study groups across the 3 time points, because this model accounts for the underlying covariance between repeated measurements (33) . The models included group, time, and group by time interaction as fixed factors controlling for the baseline value of the outcome variable and lactation status (defined as exclusive, i.e., human milk only as energy source, partial, or none based on lactation status at each study visit). Time was treated as the repeated factor, and the covariance matrix was modeled as unstructured. Data were analyzed by use of 2 different models: completers-only analysis (main analysis) and intention-to-treat analysis (ITT, sensitivity analysis). In the ITT analysis, missing values were replaced with the group-specific first and third quartile values, respectively, for that specific variable (34) . Thus, 2 different ITT models were performed to test anthropometric outcomes given that women lost to follow-up were either a group-specific "success" or "failure." Women $12 wk pregnant at a follow-up visit were excluded from all analyses.
Student's t test, Mann-Whitney U test, and x 2 test were used to test for differences in baseline characteristics between study groups and between completers and noncompleters. The difference in proportion of women in the D and C groups at (defined as within 61 kg) or below their prepregnancy weight at each study visit was tested by use of a x 2 test and logistic regression models adjusted for differences in postpartum weight retention at baseline. Postpartum weight retention was defined as measured weight at each study visit minus self-reported prepregnancy weight, and differences between study groups were analyzed by use of regression models adjusted for the baseline value. Values are presented as means 6 SDs and/or medians (1st; 3rd quartile). Data were analyzed by use of SPSS version 21.0 (IBM). Statistical significance was considered at P , 0.05.
RESULTS
Study subjects
Among the 110 randomly assigned women, 100 (91%) and 93 (85%) women remained to complete the 12-wk and 1-y follow-up, respectively (Figure 1) . During the intervention period, 10 women dropped out: 7 from the D group and 3 from the C group. Reasons for dropout at 12 wk were illness or hospitalization within the family unrelated to study participation, dissatisfaction with the intervention, and personal reasons; 4 women gave no reason. One woman reported pregnancy ,12 wk of gestation at 12 wk and was included in data analysis at both 12 wk and 1 y. Further, 7 women dropped out during the 1-y follow-up: 2 from the D group and 5 from the C group. Reasons for dropout at 1 y were illness or hospitalization within the family unrelated to study participation and time constraints; 3 women gave no reason. In addition, 8 women reported a subsequent pregnancy; of those, 4 women were at $12 wk of gestation at the 1-y follow-up. Thus, 100 (91%) and 89 (81%) women were included in the main analysis at 12 wk and 1 y, respectively. Women who dropped out during the intervention were younger (P = 0.016) and had a higher prepregnancy and baseline BMI (P = 0.032 and P = 0.028, respectively) and less education (P = 0.021) than women who remained in the trial. Women who dropped out or were excluded because of pregnancy of $12 wk of gestation at the 1-y follow-up had higher prepregnancy and baseline BMI (P = 0.011 and P = 0.007) and lower parity (P = 0.03) than women who remained in the trial. Attrition rate did not differ by study group at any follow-up (P . 0.05).
At baseline, women were 10 6 2 wk (mean 6 SD) postpartum within both study groups, had a mean age of 32.2 6 4.6 y, and the majority was highly educated (60%) and lactating (84%) ( Table 1) .
Furthermore, women had a median (1st, 3rd quartile) prepregnancy BMI of 28.4 (26.0, 32.4; range: 21.3-47.7) and a baseline BMI of 31.0 (28.8, 33.6; range: 26.3-48.7) with 61% of women classified as obese. There was no statistically significant difference in baseline weight or BMI between the D and C groups (P = 0.183 and P = 0.995); however, there was a difference in height (P = 0.022). Also, women in the D group had a higher postpartum weight retention at baseline (8.1 compared with 5.2 kg, P = 0.023), and a greater proportion of women in the D group had a weight retention of $5 kg than those in the C group (70% compared with 39%, P = 0.001). No further differences in baseline characteristics were found between the 2 groups. The proportion of women in the D and C groups reporting any lactation was 64% compared with 72% at 12 wk and 14% compared with 9% at 1 y (both P . 0.05).
Anthropometric outcome measures
Time had a statistically significant effect on weight in both groups at 12 wk and 1 y (P , 0.001), indicating that both groups lost weight during the study period. Table  2 and Figure 2 for weight loss percentage). More women in the D group than in the C group lost $5% of their baseline weight by the 12-wk follow-up (70% compared with 23% P , 0.001) and $10% by the 1-y follow-up (59% compared with 31%, P = 0.011). Further, more women in the C group than in the D group gained weight during the intervention period (17% compared with 2%, P = 0.018). The greater weight loss in the D group was accompanied by larger reductions in BMI, waist circumference, hip circumference, and body fat percentage than in the C group at 12 wk (all P , 0.01) and 1 y (all P , 0.05) ( Table 2) .
At baseline, 15% in the D group and 27% in the C group had reached their prepregnancy weight (P = 0.161). The corresponding numbers were 49% compared with 32% at 12 wk and 64% compared with 51% at 1 y (P , 0.001 and P = 0.013 in analyses adjusted for postpartum weight retention at baseline). Likewise, the D group had a smaller postpartum weight retention than the C group at 12 wk (2.1 compared with 3.0 kg, P , 0.001) and 1 y (21.1 compared with 0.3 kg, P = 0.022) after adjustment for the baseline value.
Treatment-related outcome measures
There was a statistically significant group by time interaction, with the D group achieving a greater increase in step counts at 12 wk (1187 6 2371 compared with 2542 6 2854 steps/d, P = 0.005), but not at 1 y (1053 6 2440 compared with +394 6 2857 steps/d, P = 0.322), than the C group (Table 3) . Likewise, the D group achieved a greater energy intake reduction at 12 wk [2667 (21176, 2209) compared with 2180 (2543, +191) kcal/d, P , 0.001], but not at 1 y [2630 (21056, 2150) compared with 2284 (2873, +278) kcal/d, P = 0.077], than the C group. As for macronutrients, the D group reduced their percentage of fat energy intake (P = 0.004) and increased their percentage of protein energy intake (P , 0.001) more than did the C group at 12 wk; however, only the increase in percentage of protein energy intake remained statistically significant at 1 y (P = 0.020). Furthermore, the D group decreased their percentage of saturated fat energy intake and increased their energy-adjusted intake of fiber more than did the C group at 12 wk (both P , 0.01), but these differences became statistically nonsignificant by the 1-y follow-up (P = 0.208 and P = 0.484, respectively).
Sensitivity analysis
In sensitivity analyses that used ITT, average weight loss in both groups was somewhat altered, but all between-group differences in anthropometric outcomes were maintained at both 12 wk and 1 y, irrespective of whether missing values were replaced with the group-specific first or third quartile value. Likewise, results were not altered when data were analyzed excluding all pregnant women, irrespective of gestational age at follow-up (data not shown).
DISCUSSION
The present trial was designed to evaluate the effectiveness of a diet behavior modification treatment to produce weight loss in postpartum women, and it builds on the results of a previous (38) efficacy trial (22) . We observed that women receiving diet treatment embedded in real-life settings achieved a clinically relevant weight loss of 7% after 12 wk that was sustained and further enhanced to 12% by the 1-y follow-up. These results are in line with our previous efficacy trial in which women achieved a 12-wk weight loss of 9%, which was sustained at 10% at the 1-y follow-up (22) . Previous research demonstrates varied success in generating postpartum weight loss (35) . A recent meta-analysis of postpartum lifestyle interventions found the pooled weight loss to be modest at 2.3 kg (follow-up ranging from 11 d to 3 y) and highlights that the components associated with successful outcomes are not yet clearly identified (19) . For example, Wilkinson et al. (36) evaluated a low-intensity postpartum weight program among 81 Australian women and included one face-to-face nutritional counseling session and follow-up through postal correspondence but found no difference between groups for any outcome. In contrast to the present trial, the nutrition counseling session was delivered antenatally at 36 wk of gestation. Likewise, Østbye et al. (37) enrolled 450 US women at 6 wk postpartum to a behavioral intervention with multiple healthy-eating and physical-activity classes and 6 telephone-counseling sessions over a 9-mo period but were unable to demonstrate any difference in weight, diet, or physical activity between groups. Unlike our study, a groupformat intervention was used in this trial. However, several efficacy trials have achieved successful outcomes. Colleran et al. (38) evaluated an online dietary tool combined with weekly face-to-face dietary counseling and provision of e-mail support among 27 US postpartum women and found a weight loss of 5.8 kg in the intervention group compared with 1.6 kg in minimal care after 16 wk. Similarly, individualized diet and physical activity prescriptions combined with weekly group meetings for 12 wk among 40 US women produced a weight loss of 5.6 kg after 12 wk and 7.3 kg after 1 y in the intervention group (39) . In comparison, the present trial comprised one face-to-face visit for individual counseling at the onset of treatment and thereafter biweekly and monthly feedback through telephone or e-mail correspondence, which are cost-effective and scalable channels proven to be effective in weight control (40, 41) . Thus, we demonstrate that an intervention of low intensity can provide the necessary quantity and quality of components required for a successful outcome in a real-world setting and produce weight loss of similar magnitude to more intensive programs.
The diet treatment includes several components that may contribute to its effectiveness. First, the intervention was designed to build self-efficacy and included well-established behavioral principles such as goal setting, self-monitoring, problem solving, outcome expectancies, and structured tasks to allow early mastery of behavior (42, 43) . Qualitative work from the LEVA trial revealed that the key to overcoming initial barriers to weight loss was that the dietitian provided individualized, concrete, and specific information and an emotional bond through joint commitment, trust, and accountability (18) . This suggests that a working relation with the health care provider, an individualized diet plan, and follow-up of weight loss goals are crucial elements of the treatment. Second, simple and widely accessible dietary tools such as the green keyhole and the plate model were used to communicate the diet plan. Based on data from the 24-h recalls, these tools were successfully implemented as demonstrated by the decrease in intake of fat and saturated fat and increase in intake of fiber at 12 wk. Third, women were told to self-weigh $3 times/wk to monitor weekly weight loss. A recent meta-analysis showed that studies including self-monitoring produced greater postpartum weight loss than those without (19) , and self-weighing has been associated with successful weight loss in the general population (44) . This routine was combined with personalized cell phone text messages to support implementation of treatment and provide individually tailored feedback and "pressure and praise" (18) . Likewise, the e-mail correspondence assured that women continued self-weighing and enabled the dietitian to provide guidance on how to correct small weight changes.
FIGURE 2
Percentage of weight loss at the 12-wk and 1-y follow-ups for women assigned randomly to the diet group and the control group at w10 wk postpartum in the LEVA in Real Life trial (P , 0.01 between groups at both time points as analyzed by linear regression model adjusted for baseline body weight). Numbers of women at the baseline, 12-wk, and 1-y study visits were 110, 100, and 89, respectively. Median (1st; 3rd quartile) values are presented.
These factors likely contributed to the continued weight loss in the D group after intervention termination. However, because continued weight loss was observed after intervention termination in the LEVA trial as well (in which no e-mails were provided), prepregnancy weight could also reflect a set point, with body weight set to return to this natural weight range after an episodic weight change during pregnancy (45) . Finally, most women were on maternity leave during the intervention, which most likely aided in the implementation of the treatment.
Women not receiving diet treatment in the LEVA trial and the present LEVA in Real Life trial achieved similar weight loss during the initial intervention period. However, a greater 1-y weight loss was achieved among control women in the current trial than in the LEVA trial (5% compared with 2%), and postpartum weight retention at 1 y was low in both the D and C groups in the present trial. This suggests that women in the C group might also have been influenced by study participation and changed their behavior toward a healthier lifestyle. The control group was intended to approximate a standardized usual-care condition but with the concern that offering no treatment would limit participant motivation to complete an effectiveness trial, a brochure was given to the C group, unlike in the LEVA trial. The brochure aimed to resemble general postpartum dietary guidelines provided by the Swedish National Food Administration, which are widely available on the Internet. However, printed distribution of these guidelines is not standard procedure within maternal health care, and the brochure might therefore have raised awareness of lifestyle habits beyond that of usual care. Also, the repeated weighing during follow-up visits may further have increased awareness of body weight within both groups. As a result, the difference in outcome measures reported here might underestimate the true effect of the LEVA in Real Life intervention.
There are some limitations to this trial. First, dropouts differed from women who completed the trial by being younger, having less education, and having higher BMI. However, given the robustness of our results across sensitivity analyses, it is unlikely that this has created substantial bias in the interpretation of results. Second, study dietitians were not blinded, but all outcomes were measured by use of standardized instruments and procedures. Third, the women were highly educated and motivated, which restrains external validity; however, the broad inclusion criteria enabled women with a wide range of background variables (e.g., smoking, nonlactation, and unlimited upper BMI) to enroll. Fourth, self-reported prepregnancy weight was used, and although strong validity of this variable has been demonstrated (46) , self-reported data remain prone to error. This limitation also applies to self-reported dietary intake (29, 47) , and the women might have altered their physical activity when asked to wear the pedometer device. Also, because dietary interviews were conducted Tuesday through Friday, only On the basis of completers only including pregnant women at ,12 wk of gestation at a follow-up visit. Numbers of women at the baseline, 12-wk, and 1-y study visits were 110, 100 (47 and 53 in the diet and control groups, respectively), and 89 (44 and 45 in the diet and control groups, respectively). The data were analyzed by use of linear mixed models adjusted for baseline value of the outcome variable and lactation status. LEVA, Lifestyle for Effective Weight loss during Lactation. changes in weekday dietary intake can be evaluated (29) . However, both changes in energy intake and step counts correspond fairly well to the weight trajectories of the 2 study groups. Finally, we included women with BMIs of $27, yet women with a BMI below this cutoff could also benefit from the intervention. Strengths of this trial include its randomized controlled design, long-term follow-up, relatively low attrition rate, and implementation into real-life setting to strengthen generalizability. Last, future studies should include a broader evaluation of postpartum interventions by considering that lifestyle interventions among women of reproductive age have the potential to increase the reach of intervention to family members, provide spill-over effects on subsequent pregnancies, and impede the intergenerational obesity transmission between mother and child. In conclusion, a low-intensity diet treatment delivered by a dietitian within the primary health care setting can produce clinically relevant and sustainable weight loss among postpartum women with overweight and obesity.
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